New Issue: Science’s Impossible Questions. Read Now

Nanotube-Laser Combo Selectively Targets Cancer Cells, Study Shows

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Carbon nanotubes--tiny straws of pure carbon--have many properties that make them attractive for applications as varied as nanoelectronics and nanofibers. Scientists are recruiting carbon nanotubes in the fight against cancer, too. A report published online this week by the Proceedings of the National Academy of Sciences suggests that when paired with a modified laser beam, the rods can act as tiny heaters to selectively destroy tumor cells.

When exposed to near-infrared light, carbon nanotubes quickly release excess energy as heat. Nadine Wong Shi Kam and her colleagues at Stanford University exploited this property to attack cancerous cells. "One of the longstanding problems in medicine is how to cure cancer without harming normal body tissue," notes study co-author Hongjie Dai. Cancer cells tend to be coated in folate receptors, whereas normal cells are not. Thus, to ensure that the carbon nanotubes were attracted only to diseased cells, the researchers coated them with folate molecules. The team then shined a flashlight-size near-infrared laser on aqueous solutions of both tumor and normal cells. Although harmless to regular cells, the light heated the nanotubes to 70 degrees Celsius within two minutes, killing the cancer cells they had invaded.

The researchers hope to refine the process for future use. "Folate is just an experimental model that we used," Dai says. "In reality there are more interesting ways we can do this. For example, we can attach an antibody to a carbon nanotube to target a particular type of cancer cell." To that end, Dai is currently investigating the possibility of using the technique on mice with lymphoma because lymphoma cells have well-defined surface receptors that can be targeted.

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe